CD4 T cell development and cytokine polarization: an overview - PubMed (original) (raw)
Review
CD4 T cell development and cytokine polarization: an overview
S L Swain. J Leukoc Biol. 1995 May.
Abstract
We have studied two key stages of CD4 development that serve as important checkpoints in determining whether a response will occur, how big it will be, and how long it will last. The response of naive CD4 cells is strictly regulated by the requirement for interaction of the potential precursor with an antigen-presenting cell-expressing multiple costimulatory molecules such as B7 family and intercellular adhesion molecule-1. The extent of naive cell proliferation is critically dependent on interleukin-2, whose autocrine production is similarly regulated. We show that effector CD4 cells can either die, expand, and/or generate memory. Antigen stimulation accelerates death or promotes expansion dependent on the presence of cytokines. Interleukin-2 and transforming growth factor-beta synergize to block apoptosis and favor extensive effector expansion.
Similar articles
- Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo.
Bradley LM, Harbertson J, Biederman E, Zhang Y, Bradley SM, Linton PJ. Bradley LM, et al. Eur J Immunol. 2002 Aug;32(8):2338-46. doi: 10.1002/1521-4141(200208)32:8<2338::AID-IMMU2338>3.0.CO;2-R. Eur J Immunol. 2002. PMID: 12209647 - T Cell Activation Pathways: B7, LFA-3, and ICAM-1 Shape Unique T Cell Profiles.
Wingren AG, Parra E, Varga M, Kalland T, Sjogren HO, Hedlund G, Dohlsten M. Wingren AG, et al. Crit Rev Immunol. 2017;37(2-6):463-481. doi: 10.1615/CritRevImmunol.v37.i2-6.130. Crit Rev Immunol. 2017. PMID: 29773030 Review. - Cytokine control of memory T-cell development and survival.
Schluns KS, Lefrançois L. Schluns KS, et al. Nat Rev Immunol. 2003 Apr;3(4):269-79. doi: 10.1038/nri1052. Nat Rev Immunol. 2003. PMID: 12669018 Review.
Cited by
- Protein Kinase Inhibitor-Mediated Immunoprophylactic and Immunotherapeutic Control of Colon Cancer.
Ghione S, Racoeur C, Mabrouk N, Shan J, Groetz E, Ballot E, Truntzer C, Chouchane L, Végran F, Paul C, Plenchette S, Bettaieb A. Ghione S, et al. Front Immunol. 2022 Apr 28;13:875764. doi: 10.3389/fimmu.2022.875764. eCollection 2022. Front Immunol. 2022. PMID: 35572581 Free PMC article. - CD4 T cell responses to flaviviruses.
Aberle JH, Koblischke M, Stiasny K. Aberle JH, et al. J Clin Virol. 2018 Nov;108:126-131. doi: 10.1016/j.jcv.2018.09.020. Epub 2018 Oct 3. J Clin Virol. 2018. PMID: 30312909 Free PMC article. Review. - Interleukin-5 Mediates Parasite-Induced Protection against Experimental Autoimmune Encephalomyelitis: Association with Induction of Antigen-Specific CD4+CD25+ T Regulatory Cells.
Tran GT, Wilcox PL, Dent LA, Robinson CM, Carter N, Verma ND, Hall BM, Hodgkinson SJ. Tran GT, et al. Front Immunol. 2017 Nov 1;8:1453. doi: 10.3389/fimmu.2017.01453. eCollection 2017. Front Immunol. 2017. PMID: 29163523 Free PMC article. - PILAR is a novel modulator of human T-cell expansion.
Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Engle XA, Rigby WF, Pioli PA, Guyre PM, Conejo-Garcia JR. Huarte E, et al. Blood. 2008 Aug 15;112(4):1259-68. doi: 10.1182/blood-2007-12-130773. Epub 2008 Jun 12. Blood. 2008. PMID: 18550855 Free PMC article. - Defective T cell receptor-mediated signal transduction in memory CD4 T lymphocytes exposed to superantigen or anti-T cell receptor antibodies.
Watson AR, Lee WT. Watson AR, et al. Cell Immunol. 2006 Aug;242(2):80-90. doi: 10.1016/j.cellimm.2006.09.008. Epub 2006 Nov 2. Cell Immunol. 2006. PMID: 17083922 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials